Amyloid capture and aggregation inhibition by human serum albumin
Authors:
Open Access
- 27 January 2025
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 301, 140367
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Ministerio de Ciencia e Innovación
- Xunta de Galicia (ED431B 2019/18)
- Xunta de Galicia (PID2020-120378RB-I00)
This publication has 43 references indexed in Scilit:
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- NMR and dynamic light scattering give different diffusion information for short-living protein oligomers. Human serum albumin in water solutions of metal ionsEuropean Biophysics Journal, 2022
- Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's diseaseJournal of Cellular Biochemistry, 2021
- A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR StudyAlzheimer's & Dementia, 2020
- Preparing Synthetic Aβ in Different Aggregation States2010
- Quantifying Prefibrillar Amyloids in vitro by Using a “Thioflavin‐Like” Spectroscopic MethodChemBioChem, 2010
- Dynamics of Supramolecular Association Monitored by Fluorescence Correlation SpectroscopyChemphyschem, 2008
- Diffusion Coefficients of Several Rhodamine Derivatives as Determined by Pulsed Field Gradient–Nuclear Magnetic Resonance and Fluorescence Correlation SpectroscopyJournal of Fluorescence, 2008
- Translational diffusion measured by PFG‐NMR on full length and fragments of the Alzheimer Aβ(1–40) peptide. Determination of hydrodynamic radii of random coil peptides of varying lengthMagnetic Resonance in Chemistry, 2002
- Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in PlasmaBiochemical and Biophysical Research Communications, 2000